Table 2.
Patients’ characteristics categorized in the response to treatment (n = 46)
| VR (n = 27) | NVR (n = 19) | p value | |
|---|---|---|---|
| Age | 63 ± 9 | 63 ± 9 | ns |
| M:F | 9:18 | 5:14 | ns |
| TT:TG:GG | 20:7:0 | 9:9:1 | ns |
| WBC | 4,181 ± 1,299 | 3,947 ± 1,127 | ns |
| Hb | 12.5 ± 2.0 | 13.1 ± 1.7 | ns |
| Plt | 18.1 ± 5.9 | 13.0 ± 3.6 | 0.002 |
| TP | 7.7 ± 0.6 | 7.8 ± 0.4 | ns |
| Alb | 4.4 ± 0.4 | 4.2 ± 0.3 | ns |
| AST | 46 ± 42 | 61 ± 35 | ns |
| ALT | 44 ± 44 | 73 ± 58 | ns |
| γ-GTP | 28 ± 22 | 51 ± 32 | ns |
| ChE | 293 ± 76 | 271 ± 75 | ns |
| T-cho | 178 ± 37 | 159 ± 23 | ns |
| LDL | 95 ± 22 | 88 ± 19 | ns |
| HCV RNA | 6.3 ± 0.6 | 6.3 ± 1.0 | ns |
| Core 70 (W:M) | 18:6 | 8:9 | ns |
| ISDR (0:>0) | 12:12 | 8:9 | ns |
| ARFIa | 1.20 ± 0.26 | 1.72 ± 0.34 | <0.001 |
aARFI (acoustic radiation force impulse) represents shear wave velocity (m/s)